SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 245 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,391 | -21.6% | 52 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $1,774 | +17.9% | 52 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $1,505 | +5.0% | 52 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,434 | -8.3% | 52 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,563 | -17.0% | 52 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,884 | +1.6% | 52 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,855 | +5.4% | 52 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,760 | +17.0% | 52 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,504 | -10.5% | 52 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,681 | +10.9% | 52 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,516 | +9.3% | 52 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,387 | -13.4% | 52 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,601 | +2978.8% | 52 | -96.2% | 0.00% | -66.7% |
| Q1 2021 | $52 | -96.0% | 1,361 | +2517.3% | 0.00% | +200.0% |
| Q4 2020 | $1,308 | +20.7% | 52 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,084 | -12.2% | 52 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,235 | +32.1% | 52 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $935 | -61.7% | 52 | -49.5% | 0.00% | -50.0% |
| Q4 2019 | $2,443 | – | 103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |